INCYTE CORP 4

Michael James Morrissey (EVP, Head of Tech. Operations at Incyte Corp) was granted 6,426 employee stock options at $116.69 and 8,999 performance shares of Incyte common stock as equity compensation on 2026-07-23.

On July 23, 2026, Michael James Morrissey, EVP and Head of Technical Operations at Incyte Corp, received two equity compensation awards: a stock option grant for 6,426 shares of common stock with an exercise price of $116.69 per share that vests 25% after one year and then in 36 monthly installments over the following three years, and a performance share award for 8,999 performance shares, each representing the right to receive up to 200% of a share of common stock based on Incyte’s relative total shareholder return over a three-year performance period beginning January 1, 2026, with any earned shares vesting on the third anniversary of the grant date subject to continued service. Both transactions were reported as acquisitions, are compensatory and not open-market purchases, and leave Morrissey with 6,426 stock options and 8,999 performance shares directly beneficially owned, with the ultimate value contingent on future stock price and performance outcomes.

Filing Facts

CIK

879169

Ticker

INCY

Form

4

Source Type

fda

Accession

0001780915-26-000010

Alert Tier

5